Nagla Abdel Karim, Professor of Medicine-Division of Hematology/Oncology, shared on X:
“Great start of WCLC26 learning about lung cancer policy network. Global priorities evolve toward measurable implementation as in cancer screening, tobacco control and treatment access!
Using E-Cigarettes after smoking cessation carries higher risk of lung cancer.
We are so excited and looking forward to the presidential session especially the MAVERICK data in SCLC.
Congratulations to my wonderful friend Charu Aggarwal for receiving the lectureship award! Well deserved honor! I am so happy for you my friend.
It was such a great pleasure presenting to our oligometastatic subcommittee the updates about the mini learning video modules on. Thank you to the most wonderful IASLC staff for their amazing support!
Great Work! MRI Surveillance carried less risks of cognitive impairment without difference in OS in patients with SCLC!
Fantastic Data for patients with SCLC! Tam-Peli an anti-B7-H3?ADV versus Topotecan showing significant improvement with no significant adverse events!
Thank you to IASLC and WCLC26 for supporting the first IASLC-EMRO forum where we discussed the role of lung cancer screening, non conventional smoking and participation and designing clinical trials to adapt to patients needs in the different regions of the world!
Exciting Times for SCLC! ADCs seem to be coming up next!
I am very impressed by the Brazilian Experience! Attending the Building the Bridge session with Dr. Ricardo Sales dos Santos.”
You may also be interested in: WCLC 2026 Opens in Seoul: Targeted Therapy Moves Earlier as SCLC Enters a New Therapeutic Era
